Evidence & policy library
Every pathway is linked to the organizations responsible for the decision.
16 source records
Methodology
Pathway information draws on official regulator, HTA and payer materials. Consult the cited policy for its conditions and effective date, and see Content & use for guidance on applying Atlas to your research.
Matching documents: 18
Market / scopeOfficial evidence recordTypePolicy / reference dateLast checked
Europe
🇵🇹 PortugalPT-S01 · INFARMED · About INFARMED / roleOfficialregulation, authorisation, HTA and P&R rolescurrent mandateLatest observed: current at check🇵🇹 PortugalPT-S02 · INFARMED · Avaliação de tecnologias de saúdeOfficiallifecycle HTA and DATS/CATS processSiNATS since 2015Latest observed: current at check🇵🇹 PortugalPT-S03 · INFARMED · Comparticipação / Avaliação prévia hospitalarOfficialroute differences, price and contract outputscurrent frameworkLatest observed: current at check🇵🇹 PortugalPT-S04 · INFARMED · Comissão de Avaliação de Tecnologias de SaúdeOfficialCATS role and link to DATSregulation amended 2024Latest observed: current members 2026🇵🇹 PortugalPT-S05 · INFARMED · Public funding application through SIATSOfficialsubmission, validation and assessment sequencecurrent process pageLatest observed: current at check🇵🇹 PortugalPT-S06 · INFARMED · Revisões de preçosOfficialannual/exceptional price review2026 annual rulesLatest observed: updated 2025-11 onward🇵🇹 PortugalPT-S07 · INFARMED · Sistema de Preços de ReferênciaOfficialgeneric reference reimbursement basis; quarterly group changes are product-levelcurrent law; Q3 2026 groups effective 2026-09-01Latest observed: Circular 083 of 2026-08-18🇵🇹 PortugalPT-S08 · INFARMED · Monitorização das condições de financiamentoOfficialmonitoring and reassessment outcomescurrent frameworkLatest observed: current at check🇵🇹 PortugalPT-S09 · INFARMED · Autorização de Utilização ExcecionalOfficialurgent AUE and PAP bridgeamended by DL 115/2017Latest observed: current at check🇵🇹 PortugalPT-S10 · INFARMED · Regimes excecionais de comparticipaçãoOfficialcommunity/hospital exceptional rulescurrent regimesLatest observed: current at check🇵🇹 PortugalPT-S11 · SPMS · Public framework procurement for anti-infective medicinesOfficialframework/tender price and supply boundary2026 procurementLatest observed: published 2026-03🇵🇹 PortugalPT-S12 · INFARMED · Reimbursement and price FAQOfficialcommercial start/suspension notificationscurrentLatest observed: current at check🇵🇹 PortugalPT-S13 · INFARMED · Methodological guidelines for economic evaluationOfficialpharmacoeconomic evidencecurrent methodologyLatest observed: file updated 2026🇵🇹 PortugalPT-S14 · Diário da República / INFARMED · Consolidated Decree-Law 97/2015 (SiNATS)Officialfinancing contracts and repayment mechanismslaw as amendedLatest observed: consolidated file current🇵🇹 PortugalPT-S15 · Diário da República · Decree-Law 118/2026 — current SiNATS and public-availability frameworkOfficialcurrent SiNATS basis, EU HTA integration, price/funding rules and Article 52 pilotpublished 2026-06-17; effective 2026-07-01Latest observed: official act🇵🇹 PortugalPT-S16 · European Commission / EMA · EU JCA early-information guidance and EMA IRIS coordinationOfficialscope declaration, parallel notification, product-specific upload and submission-date changes2026-08-19Latest observed: 2026-09-02🇵🇹 PortugalPT-S16 · European Commission / EMA · EU JCA early-information guidance and EMA IRIS coordinationOfficialscope declaration, parallel notification, product-specific upload and submission-date changes2026-08-19Latest observed: 2026-09-02🇵🇹 PortugalPT-S16 · European Commission / EMA · EU JCA early-information guidance and EMA IRIS coordinationOfficialscope declaration, parallel notification, product-specific upload and submission-date changes2026-08-19Latest observed: 2026-09-02For education only — not regulatory, pricing or legal advice.